| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |